131 related articles for article (PubMed ID: 12610740)
61. Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren.
Tapaninen T; Backman JT; Kurkinen KJ; Neuvonen PJ; Niemi M
J Clin Pharmacol; 2011 Mar; 51(3):359-67. PubMed ID: 20400651
[TBL] [Abstract][Full Text] [Related]
62. [Plasma levels of ropivacaine and bupivacaine during postoperative patient controlled thoracic epidural analgesia].
Gottschalk A; Burmeister MA; Freitag M; Böhme C; Standl T
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Nov; 38(11):705-9. PubMed ID: 14600860
[TBL] [Abstract][Full Text] [Related]
63. The pharmacokinetics of ropivacaine in hepatic and renal insufficiency.
Jokinen MJ
Best Pract Res Clin Anaesthesiol; 2005 Jun; 19(2):269-74. PubMed ID: 15966497
[TBL] [Abstract][Full Text] [Related]
64. Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.
Ollier E; Heritier F; Bonnet C; Hodin S; Beauchesne B; Molliex S; Delavenne X
Br J Clin Pharmacol; 2015 Jul; 80(1):67-74. PubMed ID: 25557141
[TBL] [Abstract][Full Text] [Related]
65. Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial.
Krösser S; Neugebauer R; Dolgos H; Fluck M; Rost KL; Kovar A
Eur J Clin Pharmacol; 2006 Apr; 62(4):277-84. PubMed ID: 16525816
[TBL] [Abstract][Full Text] [Related]
66. Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration.
Markowitz JS; DeVane CL
J Clin Psychopharmacol; 1999 Jun; 19(3):289-91. PubMed ID: 10350045
[No Abstract] [Full Text] [Related]
67. Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects.
Emanuelsson BM; Persson J; Sandin S; Alm C; Gustafsson LL
Ther Drug Monit; 1997 Apr; 19(2):126-31. PubMed ID: 9108638
[TBL] [Abstract][Full Text] [Related]
68. Comparative pharmacokinetics of ropivacaine and bupivacaine in nonpregnant and pregnant ewes.
Santos AC; Arthur GR; Lehning EJ; Finster M
Anesth Analg; 1997 Jul; 85(1):87-93. PubMed ID: 9212128
[TBL] [Abstract][Full Text] [Related]
69. Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation.
Harkins JD; Karpiesiuk W; Lehner A; Woods WE; Dirikolu L; Carter WG; Boyles J; Tobin T
J Vet Pharmacol Ther; 2001 Apr; 24(2):89-98. PubMed ID: 11442782
[TBL] [Abstract][Full Text] [Related]
70. Disposition kinetics of ropivacaine in humans.
Lee A; Fagan D; Lamont M; Tucker GT; Halldin M; Scott DB
Anesth Analg; 1989 Dec; 69(6):736-8. PubMed ID: 2589653
[TBL] [Abstract][Full Text] [Related]
71. Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.
Gillum JG; Israel DS; Scott RB; Climo MW; Polk RE
Antimicrob Agents Chemother; 1996 Jul; 40(7):1715-6. PubMed ID: 8807068
[TBL] [Abstract][Full Text] [Related]
72. Urinary excretion of rifampicin in the presence of ciprofloxacin.
Orisakwe OE; Afonne OJ; Agbasi PU; Ofoefule SI
Am J Ther; 2004; 11(3):171-4. PubMed ID: 15133531
[TBL] [Abstract][Full Text] [Related]
73. Direct injection of human plasma samples after ultrafiltration into programmed temperature vaporiser-gas chromatography-mass spectrometry with packed liner.
Abdel-Rehim M; Svensson KA; Askemark Y; Pettersson KJ
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):253-8. PubMed ID: 11393711
[TBL] [Abstract][Full Text] [Related]
74. Effects of tobacco smoke exposure on the kinetics of bupivacaine in mice.
Attolini L; Gantenbein M; Bruguerolle B
Life Sci; 1997; 60(10):725-34. PubMed ID: 9064477
[TBL] [Abstract][Full Text] [Related]
75. The influence of steady-state ciprofloxacin on the pharmacokinetics and pharmacodynamics of a single dose of diazepam in healthy volunteers.
Kamali F; Thomas SH; Edwards C
Eur J Clin Pharmacol; 1993; 44(4):365-7. PubMed ID: 8513847
[TBL] [Abstract][Full Text] [Related]
76. Co-administration of ciprofloxacin and cyclosporin: lack of evidence for a pharmacokinetic interaction.
Tan KK; Trull AK; Shawket S
Br J Clin Pharmacol; 1989 Aug; 28(2):185-7. PubMed ID: 2775624
[TBL] [Abstract][Full Text] [Related]
77. Assessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.
Kamali F; Ashton CH; Marsh VR; Cox J
Antimicrob Agents Chemother; 1998 May; 42(5):1256-8. PubMed ID: 9593161
[TBL] [Abstract][Full Text] [Related]
78. Acute toxicity of bupivacaine metabolites in mice.
Bruguerolle B; Attolini L; Gantenbein M
Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):997-9. PubMed ID: 7736659
[TBL] [Abstract][Full Text] [Related]
79. Effect of ciprofloxin on the pharmacokinetics of intravenous lidocaine.
Isohanni MH; Ahonen J; Neuvonen PJ; Olkkola KT
Eur J Anaesthesiol; 2005 Oct; 22(10):795-9. PubMed ID: 16211753
[TBL] [Abstract][Full Text] [Related]
80. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A; Csajka C; Merlob P; Schaefer C; Berlin M; De Santis M; Vial T; Ieri A; Malm H; Eleftheriou G; Stahl B; Rousso P; Winterfeld U; Rothuizen LE; Buclin T
J Clin Pharmacol; 2012 Dec; 52(12):1844-51. PubMed ID: 22174426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
